According to Cosmo Pharmaceuticals's latest financial reports the company's current earnings are C$0.10 Billion. In 2022 the company made an earning of C$37.33 Million a decrease over its 2021 earnings that were of C$38.66 Million. The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2022 | C$37.33 M | -3.43% |
2021 | C$38.66 M | -418.87% |
2020 | -C$12.13 Million | -64.28% |
2019 | -C$33.95 Million | 19.49% |
2018 | -C$28.41 Million | -48.67% |
2017 | -C$55.35 Million | -234.57% |
2016 | C$41.12 M | -89.6% |
2015 | C$0.39 B | 110.02% |
2014 | C$0.18 B | 33.75% |
2013 | C$0.14 B | 177.69% |
2012 | C$50.69 M | 201.84% |
2011 | C$16.79 M | 99.1% |
2010 | C$8.43 M | -22.14% |
2009 | C$10.83 M | -53.08% |
2008 | C$23.09 M | 7167.3% |
2007 | C$0.31 M | -66.41% |
2006 | C$0.94 M | -57.18% |
2005 | C$2.2 M | -193.84% |
2004 | -C$2.36 Million |